News
-
-
PRESS RELEASE
Cantourage Group SE records strong growth in revenue and EBITDA in the break-even range in 2023. Strong growth since the partial legalisation of cannabis came into force.
Cantourage Group SE reports strong revenue and EBITDA growth, reaching break-even in 2023 after partial cannabis legalization. Positive outlook for 2024 -
-
-
PRESS RELEASE
Original-Research: Cantourage Group SE (von NuWays AG): BUY
Cantourage Group SE receives a buy rating with a target price of €11, following the approval of the 'Cannabis Act' in Germany, expected to take effect on April 1st. The act will allow adults to possess cannabis and establish non-profit cannabis clubs, benefiting established players like Cantourage -
-
-
-
-
